Vancouver, Canada – May 23, 2025 – P2P Group Ltd. (CSE: PPB; OTC: PPBGF; FSE:3QG) (“P2P Group” or the “Company”) is pleased to announce the rollout of new product capabilities, the advancement of customer engagement in a key care sector, and an expansion of its sales leadership team.

Strategic Customer Engagement in Disability Care

P2P Group has also commenced engagement with a leading disability care provider, anew healthcare vertical for the Company with a customer in the APAC region, following inbound interest. This opportunity supports the Company’s expansion into critical care environments, where safety and real-time intelligence are paramount.

North American Sales Leadership Expansion

In parallel, P2P Group has initiated the recruitment of a senior sales leader to drive rapid market expansion and customer acquisition across North America, positioning the Company to capitalise on growing demand across multiple sectors.

Zones and Zone-Based Alerts Now Rolling Out

P2P Group has commenced deployment of Zones and Zone-Based Alerts, delivering enhanced spatial awareness by allowing customers to define monitored areas and receive targeted activity-based alerts. This new functionality strengthens operational safety, workflow optimisation, and real-time monitoring across healthcare, industrial, and retail sectors.

These developments reinforce P2P Group’s trajectory as a leader in AI-powered spatial intelligence, advancing its mission to transform physical spaces into smarter, safer environments.

Private Placement for Commercialisation

The Company is pleased to announce it has closed the previously announced unit offering raising $519,500. The shares will be issued five (5) business days from today,May 23, 2025, subject to any approval from the Canadian Securities Exchange (“CSE”).

The Company issued 3,996,153 units (each a “Unit”) at an issue price of CDN$0.13 perUnit. Each Unit includes one common share (“Share”) of the Company and one common share purchase warrant ("Warrant"), with each Warrant exercisable at a price ofCDN$0.18 if exercised within 12 months and CDN$0.25 if exercised after 12 months of issuance, and before the 24 month expiry period. If the volume-weighted average trading price (“VWAP”) of the Shares on the CSE exceeds CDN$0.25 for 10 consecutive trading days, the Company may accelerate the Warrant exercise period, requiring holders to act within 10 business days.

The Company would like to clarify the VWAP noted in news release dated May 21, 2025. The VWAP is if the Shares on the CSE exceeds CDN$0.25 for 10 consecutive trading days, the Company may accelerate the Warrant exercise period, requiring holders to act within 10 business days.

The Shares are subject to a 4-month hold period in all selling jurisdictions, starting from the Closing Date. Net proceeds from the offering will be used for working capital purposes. Completion of the Offering remains subject to the receipt of any required regulatory approvals, including the approval of the CSE.

‍